NO
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
64.868
Exchange
OOTC - OTC
74 %
Last period ROIC
-10%
ROIC has decreased in 5 years
What is ROIC ?
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
See also Novo Nordisk
Company Analysis
NONOF valuation, rating, competitors, insights and company profile
Eyestock Rating
NONOF financial analysis by Eyestock methodology
Valuation
NONOF valuation using historical relative method
Statements
NONOF Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NONOF dividend yield and annual dividend
The return on invested capital ratio shows how much Net Operating Profit after Tax a company earns per unit of funds involved in its core business. The value of 20% is the benchmark for Eyestock Rating calculation.
Novo Nordisk`s ROIC for the last twelve months ended 2024-06-30 is 74 %
